The phrase "clinical development process" is correct and can be used in written English.
This phrase can be used to describe the process by which a new pharmaceutical or medical device is developed and tested. For example, "The clinical development process for this new drug is estimated to take at least five years."
Overcoming these obstacles will require collaborative efforts to develop innovative strategies that address key steps in the pre-clinical and clinical development process, as well as clearly defining the global burden of GAS diseases and the molecular epidemiology of infections.
In this paper we discuss the role of IT and information systems that support incorporation of surrogate biomarkers in the clinical development process, with emphasis on new molecular imaging technologies and associated IT requirements.
Throughout the clinical development process, the perspectives of researchers, ethicists, and patients must be considered, and risks should be minimised whenever possible in a manner that is consistent with good trial design.
The company's software automates the entire clinical development process — from Phase I through regulatory submission, post-approval trials and and more.
In this role, she was responsible for Genentech's pre-clinical and clinical development, process research and development, business development and product portfolio management.
She will address medical writing for pharmaceutical, biotech, and device companies, including the documentation required for submissions to the Food and Drug Administration FDAA) during the pre-clinical and clinical development process.
The lack of performance experienced by several colloidal drug carriers during the preclinical and clinical development processes can be explained by inadequate pharmacokinetic/biodistribution profiles and/or unacceptable toxicities.
The company is a leading global provider of hosted clinical development solutions that enhance the efficiency of our customers' clinical development processes and optimize their research and development investments.
Currently, some 5-HT6 receptor ligands are being subjected to clinical development processes for future use as potential anti-dementia, anti-psychotic, and anti-obese drugs, although the mechanisms associated with the 5-HT6 receptor activation/blockade are not completely understood.
This chapter provides an overview of the clinical drug development process, which includes the clinical proof of mechanism, the clinical proof of concept, and the characterization of clinical safety.
Management guidelines have been developed through the clinical trial development process for ipilimumab and tremelimumab (Table 2) 33, 33 and strongly advise initiation of corticosteroids in any patient treated with ipilimumab in which an irAE event is suspected.
